$NVIDIA(NVDA.US)solid cashflow and good margins means that nvda will sustain better than other AI players in a downtrend. you can see this from last week to this week. Business model is intact and underwriting coreweave shows its strength!
$Oracle(ORCL.US) down today due to rate hike expectations after cpi data came in hotter than estimated. It is still holding its major support of 130 so i do not expect sell off once the market fully absorb this news within 24h. Knee jerk reactions form good buying windows!
$Broadcom(AVGO.US)micron reports tonight! It will be a barometer of where we are in the AI trade; for now i believe most chips stocks will stay flat as order books are known to public. Guidance for next year will determine if i sell it or continue to diamond hand this. Target $400.
$Eli Lilly(LLY.US)despite rivals posting encouraging clinical trial results, Eli Lily did not slide as many would expect. I believe it is their investments in R&D that will help keep it competitive in the market. Investments in their AI factory should pay off next year!
$Corning(GLW.US)
Knee jerk reaction in the last week moved the share price lower. GLW is seeking to raise $2b with at the market equity. Dilution is not a problem for me because earnings will certainly deliver in the next 2 years with the multiple deals in place.
My verdict: Good opportunity to load up!
$NVIDIA(NVDA.US)
Expect this to go back to its recent highs after earnings. Jensen has been quietly making deals behind the scenes. Not the circular financing kind that we already know. There are many ticker choices now but only one with the cashflow of a king!
$Meta Platforms(META.US)
The trial has put significant downward pressure on this ticker. However i see this as a chance to accumulate more. Trial is one off but business model is intact. My take is the fines are not priced in yet. Stay invested to capture all upsides.
$Eli Lilly(LLY.US)
Merck and moderna are good examples of what it means to get in and be patient. Lily is pumping so much money into research and with AI we might find a cure for diabetes. Get in and be patient. Trials take time for approvals. Diversify from tech!
$Zscaler(ZS.US)
Zscaler has bounced off the lows of the first half of 2026. It is an overreaction to the then sky high expectations of the entire saas ecosystem. The departure of a high profile exec added to this problem. I foresee them being essential in an AI driven world.












